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OBJECTIVE: To analyze the amount of glycosaminoglycans in the uterine cervix during each phase of the rat estrous cycle. 
DESIGN: Based on vaginal smears, forty female, regularly cycling rats were divided into four groups (n = 10 for each group): 
GI – proestrous, GII – estrous, GIII – metaestrous and GIV – diestrous. Animals were sacrificed at each phase of the cycle, and the 
cervix was immediately removed and submitted to biochemical extraction and determination of sulfated glycosaminoglycans and 
hyaluronic acid. The results were analyzed by ANOVA followed by the Bonferroni post-hoc test.
RESULTS: The uterine cervix had the highest amount of total sulfated glycosaminoglycans and dermatan sulfate during the estrous 
phase (8.90 ± 0.55 mg/g of cetonic extract, p<0.001; and 8.86 ± 0.57 mg/g of cetonic extract, p<0.001). In addition, there was 
more heparan sulfate at the cervix during the proestrous phase (0.185 ± 0.03 mg/g of cetonic extract) than during any other phase 
(p<0.001). There were no significant changes in the concentration of hyaluronic acid in the uterine cervix during the estrous cycle.
CONCLUSION: Our data suggest that the amount of total sulfated glycosaminoglycans may be influenced by hormonal fluc-
tuations related to the estrous cycle, with dermatan sulfate and heparan sulfate being the glycosaminoglycans most sensitive to 
hormonal change.
KEYWORDS: Heparan sulfate; Dermatan sulfate; Hyaluronic acid; Cervix uteri; Estrous cycle.
INTRODUCTION
Much  clinical  interest  has  been  focused  on 
glycosaminoglycans (GAGs) in all fields of medicine, as 
these molecules are related to cell recognition, migration, 
proliferation and differentiation. In addition, they are directly 
and indirectly involved with the tumorigenesis, metastasis, 
angiogenesis, immune responses, follicular development, 
embryo implantation, spermatozoa capacitation and 
infertility.1-4 
The extracellular matrix is a network of aggregates made 
up of a molecular nest containing collagen, glycoproteins, 
proteoglycans and GAG polysaccharide side chains. This 
nest maintain the cell´s structure, thus allowing organization 
of cells into tissues and ultimately permitting cell survival.5 
GAGs are also involved in various tissue functions, such as 
the hydration of the spaces surrounding cells, the formation 
of gels of various sizes and charge densities and the 
regulation of the passage of molecules to the extracellular 
environment. GAGs serve as binding sites for growth factors 
and other cell signaling proteins, which in turn function to 
block, activate or guide cell migration through the matrix.6 In 
fact, spermatozoa capacitation may be related to the binding 
of GAGs on the cell membrane of the sperm located in the 
cervix.4 
Several authors have evaluated the human endometrium 
during the reproductive ages, during pregnancy and after 704
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menopause, finding that the sulfated GAGs of this tissue 
were comprised of heparan sulfate (HS), dermatan sulfate 
(DS) and chondroitin sulfate (CS), as well as hyaluronic 
acid (HA).3,7,8 However, not much variation was found in the 
concentrations of these GAGs through the different phases 
of reproductive life, with the exception of a significant 
reduction of GAGs during gestation and a rise in CS 
among women with leiomyoma and leiomyosarcoma.3,8 
Other investigators found that the concentration of HA 
in the endometrial stroma peaked during human embryo 
implantation.9,10 Indeed, in vitro studies in both human 
and animal models have demonstrated the relevance of 
HA and its receptors in the process of implantation.  11 
Additionally, Gomes et al.12 identified DS, HS and CS in 
the murine uterine horns during all phases of the estrous 
cycle, with higher concentrations of DS and CS during 
estrous (estrogenic action) and of HS during diestrous 
(progestagenic action). However, Teixeira-Gomes et al. 
found that in a murine model, HA was more concentrated 
in the diestrous phase.13 Although these findings suggest a 
variation in uterine glycosaminoglycans during the estrous 
phase, specific knowledge concerning the concentration of 
these substances in the uterine cervix is scarce. Therefore, 
our study aimed to analyze the concentration of GAGs in the 
rat uterine cervix during each estrous cycle phase.
MATERIAL AND METHODS
Wistar female rats (Rattus norvegicus albinus) with an 
average body weight of approximately 250 g were used 
throughout the study. The rats were obtained from the Center 
for the Development of Experimental Models (CEDEME) 
of the Federal University of São Paulo – Escola Paulista de 
Medicina (UNIFESP-EPM). Experiments were approved 
(Report No. 0809/04) by the local Animal Care Committee, 
following guidelines complying with those of the Canadian 
Council on Animal Care.14
The animals (n = 10 per cage) were kept with food 
and water ad libitum at room temperature (22 ºC) with 
artificial light provided by fluorescent Phillips lamps 
(daylight model, 40 W) with a photoperiod of 12 h (lights 
on 07:00–19:00 h).
After a one-week adaptation period to the new 
environment, daily vaginal smears were taken for eight 
consecutive days to determine the periodicity of the estrous 
cycle. Based on the colpocytologic results, the animals 
were then divided into four groups of ten animals each: GI 
– proestrous; GII – estrous; GIII – metaestrous and GIV – 
diestrous.
The rats were anesthetized (xylazine 20 mg/kg plus 
ketamine 100 mg/kg, i.p.), and the female genital tract was 
dissected out. The uterine cervix was immediately removed 
and put into acetone for further biochemical analyses.
Characterization and quantification of the sulfated 
glycosaminoglycans (GAGs)
The biochemical analyses for characterization and 
quantification of the sulfated GAGs were carried out at 
the Molecular Biology Division of the Department of 
Biochemistry of the Universidade Federal de São Paulo – 
Escola Paulista de Medicina (UNIFESP – EPM).
The identification of each GAG was done using the 
following standards: chondroitin-4-sulfate from whale 
cartilage, chondroitin-6-sulfate from shark cartilage, dermatan 
sulfate from bovine intestinal mucosa (Seikagaku Kogyo 
Co., Tokyo, Japan) and heparan sulfate from bovine lung 
(extracted and purified by the Molecular Biology Division of 
the Department of Biochemistry of UNIFESP – EPM).15
To improve the identification of GAGs, controls were 
generated by enzymatic degradation of the sulfated GAGs by 
F. heparinum-derived chondroitinases. Dermatan sulfate and 
chondroitin sulfate were characterized after incubation of the 
samples with chondroitinase AC and chondroitinase ABC.
The incubation products were submitted to agarose gel 
electrophoresis, and the confirmation of the particular type 
of GAG was accomplished by the distinct band pattern in 
the agarose gel.
  The same standards were also used for quantitative 
determination of the samples by 525 nm densitometry. The 
results were expressed as μg of GAG per mg of cetonic 
extract, powder (mean ± SEM). All samples were assayed in 
triplicate. The detection limit was 1 μg/μL of GAG sulfate.
Extraction and quantification of hyaluronic acid (HA)
Determination of HA was performed using a highly 
specific, highly sensitive “ELISA-like” fluorimetric 
method that employed a biotinylated HA-binding protein 
and europium-labeled streptavidin.16 The detection limit 
of this method is ca. 0.2-500 ng/ml of HA.16 The samples 
were assayed in triplicate. The plates were read in a Victor 
2-Wallac Ou (Turku, Finland) fluorimeter.
Hormonal determination
Serum estrogen and progesterone levels were assayed in 
triplicate. Estrogen (ACS -180 Bayer, detection limit 10 pg/
ml) and progesterone (ACS– 180 Bayer, detection limit 0.1 
ng/ml) were measured by chemiluminescence with Centaur 
Bayer equipment (Bayer, Walpole, USA). Cross-reactivity 
with other steroids was <0.01%.705
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Statistical analysis
Data were expressed as the mean, median and SEM 
and were then examined for sample homogeneity using 
Bartlett’s test. When appropriate, the analysis of variance 
test (ANOVA) was performed, followed by Bonferroni’s 
post-hoc test, using SigmaStat 2.03 (SSI, Point Richmond, 
CA) software. The significance level (alpha) was set at 5%.
RESULTS 
Hyaluronic acid and the sulfated glycosaminoglycans 
dermatan sulfate (DS) and heparan sulfate (HS) were 
identified in the uterine cervix of rats during all phases of 
the estrous cycle. As shown in Table 1, the highest total 
sulfated glycosaminoglycan concentration in the rat uterine 
cervix was found during the estrous phase (8.90 ± 0.55 mg/g 
of cetonic extract, P<0.001). The cervical concentration 
of dermatan sulfate ranged from about 3.7 to 8.9 mg/g of 
cetonic extract. The highest values were detected during the 
estrous phase (8.86 ± 0.57 mg/g of cetonic extract, P<0.001). 
The heparan sulfate (HS) ranged from about 0.02 up to 
0.19 mg/g of cetonic extract. The highest among of HS was 
found during proestrous phase (0.185 ± 0.03 μg/g of cetonic 
extract, P<0.001). The electrophoretic pattern of GAGs in 
the rat uterine cervix is shown in Figure 1. We did not detect 
chondroitin-4-sulfate (4-CS), chondroitin-6-sulfate (6-CS) 
or keratan sulfate (KS). 
As shown in Table 1, DS was the main contributor to 
the total sulfated GAGs in the rat uterine cervix, reaching 
its maximal concentration at the estrous phase. During this 
phase, the level of DS was at its maximum while the levels 
of HS were at their lowest, giving rise to a DS/HS ratio 
of nearly 260:1. There was no significant change in the 
concentration of hyaluronic acid in the uterine cervix during 
the rat estrous cycle.
Serum ovarian hormones
High levels of estradiol were detected during the 
proestrous phase (29.56 ± 0.03 pg/mL, p<0.001), while 
high levels of progesterone were evident during both the 
proestrous and metaestrous phases. Table 1 shows the values 
of estradiol. 
DISCUSSION
The glycosaminoglycans (GAGs) in human cervical 
tissue consist of sulfated GAGs and hyaluronic acid 
(HA).17,18 The sulfated GAGs are primarily present in the 
form of small leucine-rich proteoglycans (SLRPs) such 
as decorin and biglycan. The SLRPs contain specific 
collagen-binding sites and contribute to the organization of 
the collagen network. Multiple studies have demonstrated 
a change in glycosaminoglycan concentrations during 
pregnancy.9 Shimizu et al.19 found that the contents of 
hyaluronic acid, chondroitin sulfate, heparan sulfate and 
acidic glycosaminoglycan increased in the postpartum cervix 
compared to the non-pregnant cervix. Dermatan sulfate 
(primarily associated with decorin) was the only GAG that 
was found to decrease with cervical remodeling. Osmers 20 
reported an increase in total GAGs during pregnancy but a 
large decrease in dermatan sulfate at the time of parturition. 
The changes in proteoglycan content were found to occur 
primarily with the onset of labor. In particular, the decrease 
in dermatan sulfate and increase in HA are believed to 
Table 1 - Concentrations of glycosaminoglycans (GAGs) extracted from uterine cervices of rats in different phases of the 
estrous cycle (mean ± SEM).
Estrous cycle phase
Proestrous Estrous Metaestrous Diestrous
Sulfated GAGs
Dermatan sulfate (mg/g of cetonic extract) 4.55 ± 0.72 8.86 ± 0.57* 3.74 ± 0.89 4.70 ± 1.37
Heparan sulfate (mg/g of cetonic extract) 0.185 ± 0.03* 0.033 ± 0.049 0.032 ± 0.025 0.025 ± 0.026
Total sulfated GAGs (mg/g of cetonic extract) 4.74 ± 0.75 8.90 ± 0.55* 3.77 ± 0.88 4.73 ± 1.33
DS/HS ratio  24.6 ± 4.24 268.5 ± 8.23 * 116.9 ± 1.06 188.0 ± 5.87
Carboxylated GAG 
Hyaluronic acid (mg/g) 9.44 ± 2.98 7.16 ± 1.53 10.92 ± 3.58 16.77 ± 11.92
Sex steroid levels
Estradiol (pg/mL) 35.56 ± 0.03*  12.21 ± 0.09 16.34 ± 0.11 21.19 ± 0.04
Progesterone (ng/mL) 12.67 ± 0.23** 3.34 ± 0.45 9.89 ± 0.19**  5.29 ± 0.33
*P<0.001 compared to other groups. DS = dermatan sulfate; HS = heparan sulfate **P<0.001 compared to the estrous or the diestrous phase706
CLINICS 2010;65(7):703-8 Glycosaminoglycan distribution in the rat uterine cervix during the estrous cycle
Cubas JJM et al.
Copyright © 2010 CLINICS
play a fundamental role in the disruption of the collagen 
network.21,22
In the rat uterine cervix, we detected HA, DS and HS 
during all phases of the estrous cycle; we did not detect 
4-CS, 6-CS or KS. However, Kofoed et al.23,24 and Cidadão 
et al. 25 reported 4- and 6-CS in the corpus of the uterus of 
prepubertal rats treated with estrogens and/or progestagens. 
In contrast, Simões et al.26 did not find 4-CS or 6-CS in the 
uterine horns of adult rats that had been ovariectomized 
(OVx) or treated with estrogens and/or progestagens. 
This finding was ascribed to factors such as the particular 
animal age or the time elapsed after OVx, which may have 
influenced the rat uterine metabolism of GAGs. In our study, 
we found high values for the DS/HS ratio during the estrous 
phase. It is important to emphasize that DS is the primary 
GAG associated with high levels of collagen. Additionally, 
this GAG may play a role in the organization of collagen 
in the uterine cervix.27 The fact that DS is critical for the 
organization of collagen is related to the decrease in ECM 
in mice, because there is less HS to form the water-retaining 
ECM.27 Changes in GAGs may reflect the quality of the 
cervical mucus. In fact, alterations in DS/HS ratios may be 
responsible for the modification of cervical mucus barrier 
properties,28 which may in turn affect the ascension of 
spermatozoids and microbial infections. 
HS is displayed on the outer side of the cell membrane, 
maintaining cell hydration in addition to binding to proteins 
of the matrix and to growth factors. In addition, HS may 
associate with a membrane protein to form a proteoglycan 
called sindecan, which is involved in cell signaling through 
interaction with integrins and tyrosine kinase receptors 
that are, in turn, associated with cell replication.2,29 It is 
Figure 1 - Typical electrophoretic pattern of sulfated glycosaminoglycans of the rat uterine cervix at each phase of the estrous cycle. Legends: CS = chon-
droitin sulfate; DS = dermatan sulfate; HS = heparan sulfate; Or = origin (at the negative pole).707
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likely that the increase in HS facilitates the ascension of 
spermatozoids during the proestrous phase. 
With respect to the reproductive capability of mice 
during the estrous cycle, the quality of cervical mucus, 
which is dependent on glycosaminoglycan composition, 
may facilitate or block spermatozoid ascension. In women, 
cervical mucus contains hyaluronic acid (3%), HS (2%) and 
DS (13%) during the secretory phase. This composition may 
reduce the water content in the mucus, which tends to be 
denser than the mucus in the first phase of menstrual cycle;30 
such a change may underlie the changes we saw in our 
experiment. This possibility will be explored in future works. 
The concentration of GAGs during the proestrous phase 
may respond to changes in the hormonal environment. It is 
conceivable that the synthesis of sulfated GAGs could be 
stimulated by estrogens but not by progestagens.23,26 However, 
the concerted action of both hormones could increase the 
tissue concentrations of GAGs, as our findings indicate.
In rats treated for 30 days with progesterone plus 
estrogens, the production of HS was inhibited in the corpus 
of the uterus, but treatment with estrogens alone caused 
stimulation.31 These data are somewhat paralleled by the 
present findings, as during metaestrous and at the beginning 
of proestrous, there was a rise in the circulating levels of 
progesterone and at the end of proestrous there was a peak 
in estrogens.32 This hormonal change during the estrous 
cycle may influence the concentration of GAGs in the 
murine uterine cervix. In fact, high levels of estrogen and 
progesterone are related to the high amounts of HS in the 
murine cervix, as our data show. It is important to emphasize 
that HS is the primary binding factor for most types of 
HPV.33 Therefore, though our findings appear to be clinically 
relevant, further studies are necessary to specifically 
investigate the relationship between contraceptive hormones 
and the amount of HS in the human uterine cervix as well 
as the HPV infection with the HS distribution during the 
menstrual cycle.
CONCLUSIONS
The concentration of the glycosaminoglycans (GAGs) 
of the cellular matrix in the rat uterine cervix varies during 
the phases of the estrous cycle; dermatan sulfate is the 
prominent GAG in the estrous phase, whereas heparan 
sulfate prevails in the proestrous phase. Overall, our results 
suggest that hormonal fluctuation related to the estrous phase 
may affect the rat uterine cervix via effects on the production 
of heparan sulfate and dermatan sulfate.
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